233 related articles for article (PubMed ID: 29517259)
21. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
[TBL] [Abstract][Full Text] [Related]
22. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
23. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
[TBL] [Abstract][Full Text] [Related]
24. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.
Welsh KA; Butters N; Mohs RC; Beekly D; Edland S; Fillenbaum G; Heyman A
Neurology; 1994 Apr; 44(4):609-14. PubMed ID: 8164812
[TBL] [Abstract][Full Text] [Related]
25. Cognitive decline in the behavioral variant of frontotemporal dementia.
Diehl-Schmid J; Bornschein S; Pohl C; Förstl H; Kurz A; Jahn T
Int Psychogeriatr; 2011 Mar; 23(2):230-7. PubMed ID: 20836915
[TBL] [Abstract][Full Text] [Related]
26. [CERAD-NP battery: Age-, gender- and education-specific reference values for selected subtests. Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)].
Luck T; Riedel-Heller SG; Wiese B; Stein J; Weyerer S; Werle J; Kaduszkiewicz H; Wagner M; Mösch E; Zimmermann T; Maier W; Bickel H; van den Bussche H; Jessen F; Fuchs A; Pentzek M;
Z Gerontol Geriatr; 2009 Oct; 42(5):372-84. PubMed ID: 19639242
[TBL] [Abstract][Full Text] [Related]
27. Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years.
Kirsebom BE; Espenes R; Hessen E; Waterloo K; Johnsen SH; Gundersen E; Botne Sando S; Rolfseng Grøntvedt G; Timón S; Fladby T
Clin Neuropsychol; 2019; 33(sup1):27-39. PubMed ID: 30849268
[No Abstract] [Full Text] [Related]
28. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.
Clark CM; Ewbank D; Lerner A; Doody R; Henderson VW; Panisset M; Morris JC; Fillenbaum GG; Heyman A
Neurology; 1997 Jul; 49(1):70-5. PubMed ID: 9222172
[TBL] [Abstract][Full Text] [Related]
29. Neuropsychological Test Norms in Cognitively Intact Oldest-Old.
Melikyan ZA; Corrada MM; Dick MB; Whittle C; Paganini-Hill A; Kawas CH
J Int Neuropsychol Soc; 2019 May; 25(5):530-545. PubMed ID: 31122309
[TBL] [Abstract][Full Text] [Related]
30. Education-Based Cutoffs for Cognitive Screening of Alzheimer's Disease.
Alenius M; Ngandu T; Koskinen S; Hallikainen I; Hänninen T; Karrasch M; Kivipelto M; Raivio MM; Laakkonen ML; Krüger J; Suhonen NM; Hokkanen L
Dement Geriatr Cogn Disord; 2022; 51(1):42-55. PubMed ID: 35196653
[TBL] [Abstract][Full Text] [Related]
31. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.
Welsh K; Butters N; Hughes J; Mohs R; Heyman A
Arch Neurol; 1991 Mar; 48(3):278-81. PubMed ID: 2001185
[TBL] [Abstract][Full Text] [Related]
32. Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease?
Zehnder AE; Bläsi S; Berres M; Spiegel R; Monsch AU
Am J Alzheimers Dis Other Demen; 2007; 22(5):416-26. PubMed ID: 17959877
[TBL] [Abstract][Full Text] [Related]
33. The RAPID-II Neuropsychological Test battery for subjects aged 20 to 49 years: Norms and cognitive profile.
Binetruy M; Mauny F; Lavaux M; Meyer A; Sylvestre G; Puyraveau M; Berger E; Magnin E; Vandel P; Galmiche J; Chopard G;
Rev Neurol (Paris); 2018; 174(1-2):44-55. PubMed ID: 28673660
[TBL] [Abstract][Full Text] [Related]
34. Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data.
Madureira S; Verdelho A; Ferro J; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
Neuroepidemiology; 2006; 27(2):101-16. PubMed ID: 16943684
[TBL] [Abstract][Full Text] [Related]
35. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis.
Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A
J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic norms of RAPID neuropsychological battery tests for subjects aged 60 to 89 years with Alzheimer's disease].
Sylvestre G; Chopard G; Tio G; Magnin E; Rumbach L; Vandel P; Galmiche J
Rev Neurol (Paris); 2011; 167(6-7):495-504. PubMed ID: 21474155
[TBL] [Abstract][Full Text] [Related]
37. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries.
Lee JH; Lee KU; Lee DY; Kim KW; Jhoo JH; Kim JH; Lee KH; Kim SY; Han SH; Woo JI
J Gerontol B Psychol Sci Soc Sci; 2002 Jan; 57(1):P47-53. PubMed ID: 11773223
[TBL] [Abstract][Full Text] [Related]
38. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
Barth S; Schönknecht P; Pantel J; Schröder J
Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
[TBL] [Abstract][Full Text] [Related]
39. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.
Davidson M; Harvey P; Welsh KA; Powchik P; Putnam KM; Mohs RC
Am J Psychiatry; 1996 Oct; 153(10):1274-9. PubMed ID: 8831434
[TBL] [Abstract][Full Text] [Related]
40. The CERAD Neuropsychological Assessment Battery Is Sensitive to Alcohol-Related Cognitive Deficiencies in Elderly Patients: A Retrospective Matched Case-Control Study.
Kaufmann L; Huber S; Mayer D; Moeller K; Marksteiner J
J Int Neuropsychol Soc; 2018 Apr; 24(4):360-371. PubMed ID: 29103404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
